Armata Pharmaceuticals, Inc. (ARMP)
AMEX·Healthcare·Biotechnology
$9.56
-13.14%
Mkt Cap $473.30M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | $740.00K | $1.10M | +48.65% | -$0.19 | -$0.51 | -168.42% | — | — |
| Q4 2025 Nov 12, 2025 | $740.00K | $1.16M | +56.62% | -$0.42 | -$0.42 | +0.00% | — | — |
| Q3 2025 Aug 12, 2025 | $1.38M | $2.17M | +57.17% | -$0.39 | -$0.32 | +17.95% | — | — |
| Q2 2025 May 14, 2025 | $1.38M | $491.00K | -64.42% | -$0.38 | -$0.20 | +47.37% | — | — |
| Q1 2025 Mar 20, 2025 | $1.56M | $1.24M | -20.83% | -$0.35 | -$0.23 | +34.29% | — | — |
| Q4 2024 Nov 13, 2024 | $1.56M | $2.97M | +90.58% | -$0.28 | -$0.15 | +46.43% | — | — |
| Q3 2024 Aug 13, 2024 | $1.13M | — | — | -$0.52 | -$0.65 | -25.00% | — | — |
| Q2 2024 May 7, 2024 | $1.15M | $966.00K | -16.00% | -$0.28 | -$0.69 | -146.43% | — | — |
| Q1 2024 Mar 21, 2024 | $860.00K | $1.53M | +77.67% | -$0.35 | -$0.55 | -57.14% | — | — |
| Q4 2023 Nov 14, 2023 | $860.00K | $1.23M | +42.44% | -$0.33 | -$0.31 | +6.06% | — | — |
| Q3 2023 Aug 14, 2023 | $1.81M | $980.00K | -45.86% | -$0.35 | -$0.28 | +20.00% | — | — |
| Q2 2023 May 11, 2023 | $1.78M | $796.00K | -55.28% | -$0.29 | -$0.40 | -37.93% | — | — |
| Q1 2023 Mar 16, 2023 | $1.67M | $1.05M | -37.07% | -$0.25 | -$0.29 | -16.00% | — | — |
| Q4 2022 Nov 9, 2022 | $1.64M | $1.34M | -18.41% | -$0.27 | -$0.24 | +11.11% | — | — |
| Q3 2022 Aug 11, 2022 | $1.13M | $1.88M | +67.38% | -$0.26 | -$0.26 | +0.00% | — | — |
| Q2 2022 May 12, 2022 | $975.00K | $1.24M | +26.77% | -$0.20 | -$0.30 | -50.00% | — | — |
| Q1 2022 Mar 17, 2022 | $775.00K | $2.14K | -99.72% | -$0.25 | -$0.23 | +8.00% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.26 | -$0.22 | +15.38% | — | — |
| Q3 2021 Aug 12, 2021 | $1.17M | $1.17M | +0.00% | -$0.25 | -$0.25 | +0.00% | — | — |
| Q2 2021 May 13, 2021 | — | $1.07M | — | -$0.28 | -$0.27 | +3.57% | — | — |